Health · Public Health & Disease · 2 hrs ago
Joint flu and Covid-19 vaccination campaign starts on 13 October
A joint vaccination campaign against flu and Covid-19 is due to begin on 13 October 2026.
Cases of respiratory viruses have increased since September.
The campaign covers both flu and Covid-19.
The flu vaccination campaign is scheduled to end on 31 January 2027.
The increase in cases has raised questions about why vaccinations did not start earlier.
The information available does not say who sets the start date or explain why it was chosen.
The next stated date is the start of the campaign on 13 October.
France’s joint vaccination campaign against influenza and Covid-19 begins on 13 October 2026.
The influenza vaccination campaign is scheduled to end on 31 January 2027.
The campaign starts amid an increase in respiratory virus cases reported since September.
Ouest-France examined why vaccinations did not begin earlier and who sets the schedule.
- Who
- People receiving the joint influenza and Covid-19 vaccination campaign.
- What
- The joint vaccination campaign begins.
- When
- 13 October 2026; the influenza campaign ends on 31 January 2027.
- Where
- Not stated
- Why
- Not stated
This story does not have two clearly opposing sides.
No direct quotes in the coverage so far.
Cases of respiratory viruses began multiplying, according to Ouest-France.
The joint influenza and Covid-19 vaccination campaign begins.
The influenza vaccination campaign is scheduled to end.
- Campaign start
- 13 October 2026
- Influenza campaign end
- 31 January 2027
- Context
- Respiratory virus cases have multiplied since September
Sources
Related news
Tokat suspends classes as thousands seek care for stomach symptoms
Measles cases top 55,000 in the Americas as health agency urges vaccination
Study identifies five ways to reduce vaccine hesitancy
WHO says cause of Russian lab worker’s death remains unknown
Russia ends checks after Siberian lab worker’s death, but cause remains unknown
Singapore mosques to stay open for prayers as haze worsens
Survey finds rising heat-related risks for pregnant women and newborns
About 1,300 to 1,400 people seek care after illness in Tokat
Brazil approves first human tests of vaccine against a major malaria parasite
Drug-resistant Shigella is becoming more common in the U.S
Kenya’s First Ebola Patient Travelled Through DR Congo and Uganda Undetected
